DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
U.S. Food and Drug Administration (FDA).
Summary products characteristicas: Mirabegron (Myrbetriq).
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202611s011lbl.pdf Published 2012. Accessed June 1, 2020.
We do not assume any responsibility for the contents of the web pages of other providers.